HC Wainwright & Co. Maintains Buy on Biomea Fusion, Raises Price Target to $40

Benzinga · 09/27 17:38
HC Wainwright & Co. analyst Joseph Pantginis maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and raises the price target from $15 to $40.